The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 02, 2021

Filed:

Sep. 27, 2017
Applicant:

Us Kidney Research Corporation, Roseville, CA (US);

Inventors:

Jamie Allen Hestekin, Fayetteville, AR (US);

Christa Noel Hestekin, Fayetteville, AR (US);

Grace Ann C. Morrison, Springdale, AR (US);

Sadia Ali Paracha, Fayetteville, AR (US);

Assignee:

US Kidney Research Corporation, Roseville, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01D 61/44 (2006.01); A61M 1/16 (2006.01); A61M 1/10 (2006.01); A61N 1/00 (2006.01); A61M 1/34 (2006.01); B01D 61/50 (2006.01); B01D 61/58 (2006.01); B01D 61/02 (2006.01); B01D 61/32 (2006.01); B01D 61/48 (2006.01); C02F 9/00 (2006.01); B01D 61/54 (2006.01); B01D 61/12 (2006.01); B01D 61/14 (2006.01); B01D 61/28 (2006.01); B01D 61/24 (2006.01); A61M 1/28 (2006.01); A61M 1/36 (2006.01); A61M 1/12 (2006.01); C02F 1/44 (2006.01); C02F 1/469 (2006.01);
U.S. Cl.
CPC ...
A61M 1/1696 (2013.01); A61M 1/1006 (2014.02); A61M 1/1605 (2014.02); A61M 1/1654 (2013.01); A61M 1/1678 (2013.01); A61M 1/3472 (2013.01); A61M 1/3482 (2014.02); A61N 1/00 (2013.01); B01D 61/022 (2013.01); B01D 61/12 (2013.01); B01D 61/145 (2013.01); B01D 61/246 (2013.01); B01D 61/28 (2013.01); B01D 61/32 (2013.01); B01D 61/44 (2013.01); B01D 61/445 (2013.01); B01D 61/48 (2013.01); B01D 61/485 (2013.01); B01D 61/50 (2013.01); B01D 61/54 (2013.01); B01D 61/58 (2013.01); C02F 9/00 (2013.01); A61M 1/12 (2013.01); A61M 1/165 (2014.02); A61M 1/1649 (2014.02); A61M 1/28 (2013.01); A61M 1/3639 (2013.01); A61M 2205/3331 (2013.01); A61M 2209/088 (2013.01); B01D 2311/243 (2013.01); B01D 2311/2684 (2013.01); B01D 2313/40 (2013.01); B01D 2317/02 (2013.01); B01D 2325/42 (2013.01); C02F 1/441 (2013.01); C02F 1/442 (2013.01); C02F 1/444 (2013.01); C02F 1/4695 (2013.01);
Abstract

A device and method are described for the treatment of blood, which device may be used in conjunction with or in place of a failed Kidney. The device includes an ultrafiltration unit to remove proteins, red and white blood cells and other high molecular weight components, a nanofiltration unit to remove glucose, at least one electrodeionization unit to transport ions from the blood stream, and a reverse osmosis unit to modulate the flow of water, to both the blood and urine streams. In one embodiment, a specialized electrodeionization unit is provided having multiple chambers defining multiple dilute fluid channels, each channel filled with an ion specific resin wafer, and electrodes at the extremity of the device and proximate each of the resin filled dilute channels. By selective application of voltages to these electrodes, the ion transport functionality of a given dilute channel can be turned on or off.


Find Patent Forward Citations

Loading…